Common Mistakes to Avoid While Installing Sampling Booths in Pharma Facilities

In the highly regulated pharmaceutical industry, even minor lapses in facility design can lead to serious compliance issues, product contamination, and operational inefficiencies. One of the most critical yet often underestimated installations is the sampling booth in the pharmaceutical industry. Sampling booths play a vital role in controlling contamination during raw material dispensing and sampling processes.

However, improper planning, incorrect installation, or a lack of regulatory understanding can significantly reduce their effectiveness. This blog explores the most common mistakes to avoid while installing sampling booths in pharma facilities, ensuring GMP compliance, operator safety, and smooth production workflows.

1. Ignoring GMP and Regulatory Guidelines

One of the biggest mistakes pharmaceutical companies make is installing sampling booths without fully aligning with GMP, WHO, and ISO standards. Sampling booths are not just enclosures; they are contamination-control systems designed to protect both product and personnel.

Failing to consider airflow direction, pressure differentials, and filtration efficiency can lead to audit observations or even production shutdowns. A properly designed sampling booth in the pharmaceutical industry must ensure unidirectional airflow and adequate containment as per regulatory norms.

2. Poor Airflow and Filtration Design

Incorrect airflow design is a frequent and costly error. Sampling booths rely heavily on HEPA-filtered air to maintain cleanliness levels and prevent cross-contamination.

Common airflow-related mistakes include:

• Inadequate air changes per hour (ACH)

• Poor exhaust positioning

• Incorrect pressure balance with adjacent rooms

Such errors can cause dust accumulation, operator exposure, and compromised product quality—especially when handling potent APIs.

Best Practice: Conduct airflow visualisation and performance qualification (PQ) after installation.

3. Choosing the Wrong Booth Size

Many pharma facilities underestimate the importance of booth sizing. Installing a booth that is too small restricts operator movement, while an oversized booth can disrupt airflow efficiency and increase operational costs.

Sampling booths should be designed based on:

• Material batch size

• Container dimensions

• Number of operators

• Type of raw material handled

4. Lack of Integration with Production Equipment

A major oversight is treating the sampling booth as an isolated unit rather than integrating it with upstream and downstream equipment, such as the High Shear Mixer Granulator and Tablet Coating Machine.

Poor integration leads to:

• Material handling delays

• Increased contamination risk during transfer

• Inefficient workflow between sampling, granulation, and coating stages

Smart facilities plan sampling booth placement near dispensing and granulation areas to optimise production flow.

5. Inadequate Material and Construction Quality

Using substandard materials is a long-term risk. Sampling booths must withstand frequent cleaning, chemical exposure, and continuous operation.

Common mistakes include:

• Low-grade stainless steel

• Poor surface finish leading to dust retention

• Non-compliant gasket and sealing materials

These issues compromise cleanability and regulatory acceptance.

6. Overlooking Operator Safety and Ergonomics

Sampling booths are designed to protect operators from exposure to airborne particles. Ignoring ergonomic factors such as working height, glove port positioning, and visibility can lead to operator fatigue and safety risks.

Poor ergonomic design can result in:

• Improper sampling techniques

• Increased handling errors

• Reduced productivity

A well-designed sampling booth in the pharmaceutical industry balances containment with operator comfort.

7. Improper Exhaust and Dust Collection Planning

Many installations fail to manage exhaust air and dust collection systems properly. Without effective dust extraction, fine particles may escape into surrounding cleanroom areas.

This becomes particularly critical when handling materials that later move into sensitive processes involving a high-shear mixer granulator or tablet coating machine, where contamination can directly impact product quality.

8. Ignoring Turnkey Project Expertise

Pharmaceutical companies often rely on multiple vendors for HVAC, equipment, and cleanroom construction, which can lead to coordination issues. Lack of centralised responsibility increases the risk of design mismatches and delayed validation.

Opting for turnkey project solutions helps eliminate these risks by offering:

• Single-point accountability

• Integrated design and execution

• Faster validation and commissioning

Turnkey solutions ensure that sampling booths align seamlessly with cleanrooms, utilities, and production equipment.

9. Skipping Validation and Qualification

Installing a sampling booth without proper DQ, IQ, OQ, and PQ is a critical compliance failure. Many facilities rush into production without validating airflow patterns, filter integrity, and containment efficiency.

This oversight can result in:

• Audit non-compliance

• Revalidation costs

• Production delays

10. Not Planning for Future Scalability

Another common mistake is designing sampling booths only for current needs. As product portfolios expand and production volumes increase, facilities may struggle with outdated infrastructure.

Future-ready sampling booths should consider:

• Modular design

• Capacity expansion

• Compatibility with advanced equipment like an upgraded High Shear Mixer Granulator or a high-capacity Tablet Coating Machine.

Conclusion

Installing a sampling booth is not just a compliance requirement—it is a strategic investment in product quality, operator safety, and manufacturing efficiency. Avoiding these common mistakes ensures smooth operations, regulatory approval, and long-term reliability.